Yasemin Ataman-Onal

USPTO Granted Patents = 12 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 6(Granted Patents)

Location History:

Reyriux, FR (2016)
Lyons, FR (2013 - 2019)
Reyrieux, FR (2013 - 2022)

Company Filing History:

Centre National De La Recherche Scientifique

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12298298 - Method for detecting an immune cellular response (2025-05-13),

2. 11225518 - Method for preparing anti-AMH antibodies and uses of same (2022-01-18),

3. 10591482 - Method of assaying Apolipoprotein AI for the in vitro diagnosis of colorectal cancer (2020-03-17),

4. 10465012 - Bioresorbable nonlamellar microparticles and uses thereof (2019-11-05),

5. 10408841 - Mutated HEV polypeptides and the use thereof for assaying anti-HEV antibodies (2019-09-10),

6. 9890196 - Ezrin assay method for the in vitro diagnosis of colorectal cancer (2018-02-13),

7. 9726670 - Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer (2017-08-08),

8. 9433674 - Composition comprising a colloidal synthetic bioresorbable vector and a viral vector (2016-09-06),

9. 9388404 - Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer (2016-07-12),

10. 8735078 - Apolipoprotein AII assay method for the in vitro diagnosis of colorectal cancer (2014-05-27),

11. 8377477 - Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof (2013-02-19),

12. 8367806 - Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer (2013-02-05),

Title: The Innovative Mind of Yasemin Ataman-Onal: A Trailblazer in Antibody Research

Introduction: Yasemin Ataman-Onal is a remarkable inventor based in Reyrieux, France. With an impressive portfolio of 11 patents, her work significantly contributes to the fields of biochemistry and fertility research. Her innovative methods pave the way for advancements in medical diagnostics and treatment.

Latest Patents: Among her latest patents is a groundbreaking method for preparing anti-mammalian Anti-Müllerian Hormone (AMH) antibodies. This invention encompasses the steps to create these antibodies and unlocks their potential applications for assaying AMH, particularly in fertility assessments. Another notable patent focuses on the in vitro diagnosis of colorectal cancer. This method involves assaying the levels of Apolipoprotein AI, Apolipoprotein AII, E-Cadherin, and Galectin-3 in biological samples from individuals suspected of having colorectal cancer, with the sample taken remote from any tumor.

Career Highlights: Yasemin has contributed to significant projects during her career, working with esteemed organizations such as bioMérieux, Inc. and the Centre National de la Recherche Scientifique. Her expertise in the field is well recognized, making her an influential figure in research and development.

Collaborations: Throughout her impactful career, Yasemin has collaborated with notable peers, including Jean-Philippe Charrier and Geneviève Choquet-Kastylevsky. These partnerships have fostered a creative exchange of ideas, enhancing research outcomes and innovation.

Conclusion: In summary, Yasemin Ataman-Onal exemplifies the spirit of innovation in the realm of biomedical research. Her patents reflect a profound commitment to enhancing healthcare through novel scientific methodologies. As she continues to advance her research, the impact of her work will undoubtedly resonate across the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.